Search the NICE 'do not do' recommendations database
You can search the NICE 'do not do' recommendations database by:
- typing in a specific term in the 'do not do' recommendations box
- selecting an appropriate topic
- selecting the type of source guidance.
To see the full list of all NICE 'do not do' recommendations leave all the fields blank and click the 'Search' button.
Gastrointestinal stromal tumours (unresectable/metastatic) - imatinib
|Guidance ID||NICE 'do not do' recommendation||Interventions|
|TA209||Imatinib at 600 or 800 mg/day is not recommended for people with unresectable and/or metastatic gastrointestinal stromal tumours whose disease has progressed after treatment with 400 mg/day imatinib.||imatinib (600mg/day or 800mg/day)|
This page was last updated: 24 February 2014